Core Scientific (CORZ) Notes Payables (2021 - 2025)

Core Scientific has disclosed Notes Payables across 5 years of filings, most recently posting $16.2 million for Q1 2025.

• Notes Payables for Q1 2025 came in at $16.2 million, down 30.51% year-over-year; the trailing twelve-month figure through Mar 2025 was $16.2 million (down 30.51% YoY), and the FY2024 annual result was $16.3 million, down 86.9% from the prior year.
• Notes Payables came in at $16.2 million for Q1 2025 at Core Scientific, roughly flat from $16.3 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $977.6 million in Q3 2022 to a low of $16.2 million in Q1 2025.
• The 5-year median for Notes Payables is $35.9 million (2022), against an average of $130.4 million.
• Peak annual rise in Notes Payables reached 243.13% in 2023, while the deepest fall reached 87.28% in 2023.
• Core Scientific's Notes Payables stood at $76.0 million in 2021, then slumped by 52.31% to $36.2 million in 2022, then soared by 243.13% to $124.4 million in 2023, then plunged by 86.9% to $16.3 million in 2024, then decreased by 0.47% to $16.2 million in 2025.
• The last three Notes Payables figures came in at $16.2 million (Q1 2025), $16.3 million (Q4 2024), and $17.9 million (Q3 2024), per Business Quant data.